The China cardiology information system market is projected to reach USD 54 million by 2024 from USD 35 million in 2019, at a CAGR of 8.9%. Growth in this market is driven by the rising incidence of cardiovascular disease in China, government initiatives for HCIT development, and the increasing number of hospitals in China. Moreover, the use of cloud-based solutions is expected to provide growth opportunities for players in the China cardiology information system market during the forecast period. On the other hand, integration and interoperability issues pose major challenges for solution vendors in this market. Key players in the China cardiology information system market include Philips Healthcare (Netherlands), CREALIFE Medical Technology (China), Central Data Network (Australia), Infinitt Healthcare (South Korea), and Esaote (Italy).
In 2018, CREALIFE Medical Technology (China) dominated the China cardiology information technology market. The company is engaged in the R&D and supply of medical image process technology and Internet solutions. It provides high-grade analysis of medical images and advanced international specialized solutions. Moreover, CREALIFE provides integration solutions for medical images and information networks, such as PACS, CVnet, RIS, and TELEMED. To maintain its brand image, in 2016, CREALIFE exhibited its cardiovascular information system products at the ESC Congress held in Rome. Moreover, in 2018, the company exhibited its products related to cardiovascular systems at an exhibition held by the Radiological Society of North America
To know about the assumptions considered for the study download the pdf brochure
Philips Healthcare (Netherlands) is the second-largest player in the China cardiology information system market. The company operates in the areas of diagnostics and treatment, connected care and health informatics, personal health, and others. The company provides cardiology IT systems through its connected care and health informatics segment. The company is a well-established brand and has been present in the market for nearly a decade, which gives it a competitive edge over other players. The company is innovation-centric and invests heavily in R&D for maintaining its market share. Its customer-oriented focus has ensured strong relationships with customers, which is another factor that has supported its leadership in the China cardiology information system market.
Cardiology Information System Market by System (Standalone, Integrated System, Cardiology Information System, Cardiology PACS), Component (Software, Services, Hardware), & End User (L3A Hospital, L3B and L2 Hospital) - China Forecast to 2024
Mr. Shelly Singh
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE